-
1
-
-
84880535720
-
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
-
Green RC, Berg JS, Grody WW, et al.; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574.
-
(2013)
Genet Med
, vol.15
, pp. 565-574
-
-
Green, R.C.1
Berg, J.S.2
Grody, W.W.3
-
2
-
-
84907493840
-
Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues)
-
Weiner C. Anticipate and communicate: ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts (December 2013 report of the Presidential Commission for the Study of Bioethical Issues). Am J Epidemiol 2014;180:562-564.
-
(2014)
Am J Epidemiol
, vol.180
, pp. 562-564
-
-
Weiner, C.1
-
3
-
-
84920528362
-
ACMG policy statement: Updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing
-
ACMG Board of Directors. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 2015;17:68-69.
-
(2015)
Genet Med
, vol.17
, pp. 68-69
-
-
-
4
-
-
84920545337
-
Reporting genomic secondary findings: ACMG members weigh in
-
Scheuner M T, Peredo J, Benkendorf J, et al. Reporting genomic secondary findings: ACMG members weigh in. Genet Med 2015;17:27-35.
-
(2015)
Genet Med
, vol.17
, pp. 27-35
-
-
Scheuner, M.T.1
Peredo, J.2
Benkendorf, J.3
-
5
-
-
84930526399
-
ClinGen-The Clinical Genome Resource
-
ClinGen
-
Rehm HL, Berg JS, Brooks LD, et al.; ClinGen. ClinGen-the Clinical Genome Resource. N Engl J Med 2015;372:2235-2242.
-
(2015)
N Engl J Med
, vol.372
, pp. 2235-2242
-
-
Rehm, H.L.1
Berg, J.S.2
Brooks, L.D.3
-
6
-
-
85000578287
-
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation
-
Hunter JE IS, Biesecker LG, Buchanan A, et al. A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genet Med. 2016;18:467-475.
-
(2016)
Genet Med.
, vol.18
, pp. 467-475
-
-
Hunter, J.E.I.S.1
Biesecker, L.G.2
Buchanan, A.3
-
7
-
-
85011909790
-
-
ClinGen. Actionability Working Group Evidence-based Summaries Accessed 23 August, 2016
-
ClinGen. Actionability Working Group Evidence-based Summaries. https://clinicalgenome.org/working-groups/actionability/projects-initiatives/actionability-evidence-based-summaries. Accessed 23 August, 2016.
-
-
-
-
8
-
-
78249244459
-
Mutations in myosin light chain kinase cause familial aortic dissections
-
Wang L, Guo DC, Cao J, et al. Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet 2010;87:701-707.
-
(2010)
Am J Hum Genet
, vol.87
, pp. 701-707
-
-
Wang, L.1
Guo, D.C.2
Cao, J.3
-
11
-
-
46249112793
-
Diagnosis and treatment of Wilson disease: An update
-
Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-2111.
-
(2008)
Hepatology
, vol.47
, pp. 2089-2111
-
-
Roberts, E.A.1
Schilsky, M.L.2
-
12
-
-
33846582913
-
Wilson's disease
-
Ala A, Walker A P, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
-
(2007)
Lancet
, vol.369
, pp. 397-408
-
-
Ala, A.1
Walker, A.P.2
Ashkan, K.3
Dooley, J.S.4
Schilsky, M.L.5
-
15
-
-
0027074530
-
The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency
-
Tuchman M. The clinical, biochemical, and molecular spectrum of ornithine transcarbamylase deficiency. J Lab Clin Med 1992;120:836-850.
-
(1992)
J Lab Clin Med
, vol.120
, pp. 836-850
-
-
Tuchman, M.1
-
16
-
-
0022642207
-
Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency
-
Batshaw ML, Msall M, Beaudet AL, Trojak J. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr 1986;108:236-241.
-
(1986)
J Pediatr
, vol.108
, pp. 236-241
-
-
Batshaw, M.L.1
Msall, M.2
Beaudet, A.L.3
Trojak, J.4
-
17
-
-
0347949709
-
Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency
-
Gyato K, Wray J, Huang ZJ, Yudkoff M, Batshaw ML. Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 2004;55:80-86.
-
(2004)
Ann Neurol
, vol.55
, pp. 80-86
-
-
Gyato, K.1
Wray, J.2
Huang, Z.J.3
Yudkoff, M.4
Batshaw, M.L.5
-
18
-
-
0035145334
-
Alternative pathway therapy for urea cycle disorders: Twenty years later
-
discussion S54
-
Batshaw ML, MacArthur RB, Tuchman M. Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 2001;138(1 suppl):S46-54; discussion S54.
-
(2001)
J Pediatr
, vol.138
, Issue.1
, pp. S46-54
-
-
Batshaw, M.L.1
MacArthur, R.B.2
Tuchman, M.3
-
19
-
-
84947963796
-
-
GeneReviews. University of Washington, Seattle, WA
-
Lichter-Konecki U, Caldovic L, Morizono H, et al. Ornithine Transcarbamylase Deficiency. GeneReviews. University of Washington, Seattle, WA, 2016.
-
(2016)
Ornithine Transcarbamylase Deficiency
-
-
Lichter-Konecki, U.1
Caldovic, L.2
Morizono, H.3
-
20
-
-
84928209346
-
Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
-
Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424.
-
(2015)
Genet Med
, vol.17
, pp. 405-424
-
-
Richards, S.1
Aziz, N.2
Bale, S.3
-
21
-
-
84959299788
-
Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1, 696 neonates
-
Bodian DL, Klein E, Iyer RK, et al. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1, 696 neonates. Genet Med 2016;18:221-230.
-
(2016)
Genet Med
, vol.18
, pp. 221-230
-
-
Bodian, D.L.1
Klein, E.2
Iyer, R.K.3
-
22
-
-
84949266797
-
Potential uses and inherent challenges of using genome-scale sequencing to augment current newborn screening
-
Berg JS, Powell CM. Potential uses and inherent challenges of using genome-scale sequencing to augment current newborn screening. Cold Spring Harb Perspect Med. 2015;5:pii: a023150.
-
(2015)
Cold Spring Harb Perspect Med.
, vol.5
-
-
Berg, J.S.1
Powell, C.M.2
|